Lazard Asset Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Buy |
99,858
+39,278
| +65% | +$907K | ﹤0.01% | 969 |
|
|
2025
Q1 | $1.64M | Sell |
60,580
-21,425
| -26% | -$578K | ﹤0.01% | 1034 |
|
|
2024
Q4 | $4.39M | Buy |
+82,005
| New | +$4.39M | 0.01% | 668 |
|
|
2024
Q1 | – | Sell |
-1,734
| Closed | -$18K | – | 2219 |
|
|
2023
Q4 | $18K | Buy |
1,734
+67
| +4% | +$696 | ﹤0.01% | 2063 |
|
|
2023
Q3 | $16K | Buy |
+1,667
| New | +$16K | ﹤0.01% | 2122 |
|